Navigation Links
Labopharm announces details for first quarter results conference call and annual meeting
Date:5/1/2008

rmance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is being commercially launched in key markets globally. The Company also has a robust pipeline of follow-on products in both pre-clinical and clinical development. Labopharm's vision is to become an integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize its own products. For more information, please visit http://www.labopharm.com.

This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors, including the uncertainties related to the outcomes of clinical trials, the regulatory process in various countries for the approval of the Company's products and the successful commercialization of the products throughout the world if they are approved. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.


'/>"/>
SOURCE Labopharm Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Labopharm Appoints Dr. Claire Brulle as Senior Vice-President and Chief Medical Officer
2. Labopharm Appeals FDAs Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy
3. Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
4. Labopharms Once-Daily Tramadol Approved in South Korea and Australia
5. Labopharm to host conference call Thursday, February 21, 2008 at 8:30 a.m. (ET)
6. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
7. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
8. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
9. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
10. Labopharm Reports Results for Third Quarter Fiscal 2007
11. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... May 30, 2015 Promising clinical trial ... (ASCO) Annual Meeting 2015 show activity of the investigational ... case specifically against brain metastases and in another case ... patients. , "I am thrilled to have been able ... early 40s. She didn't have any other great treatment ...
(Date:5/30/2015)... May 30, 2015 On Thursday, ... Dr. Charles Simone and Dr. Evan Alley both ... ‘Meet the Mesothelioma Experts’ series. The interview was ... mesothelioma centers of excellence. Drs. Simone and Alley ... Mary Hesdorffer, with whom they discussed the mesothelioma ...
(Date:5/30/2015)... 30, 2015 Nicole Blodgett, Vice ... Income Associate (DIA) designation to further her expertise ... is designed for insurance advisors, health care professionals, ... knowledge and expertise associated with the risk and ... designation is only the latest accomplishment in Nicole's ...
(Date:5/30/2015)... May 30, 2015 San Luis ... she is offering a free analysis and consultation for ... coincides with Disability Awareness Month, which was created by ... across the United States such as Polk recognize the ... awareness about the possibility of disability, as well as ...
(Date:5/30/2015)... A live auction will be held to ... surgery centers and other medical facilities around the United ... radiology, surgery, endoscopy, lab, anesthesia, exam and much more. ... June 2nd starting at 10:00am EDT. The equipment is ... Hiatus Rd., Sunrise, FL 33351. Anyone can participate ...
Breaking Medicine News(10 mins):Health News:ONT-380 has Stage IV HER2+ Breast Cancer Patient 'Worrying About Normal Stuff Again' 2Health News:ONT-380 has Stage IV HER2+ Breast Cancer Patient 'Worrying About Normal Stuff Again' 3Health News:Interview with Mesothelioma Experts, Drs. Simone and Alley Now Available on Demand 2Health News:Secura Consultants Expands Disability Insurance Expertise 2Health News:San Luis Obispo Insurance Agent Susan Polk Offering Complementary Insurance Analysis In Honor Of Disability Awareness Month 2Health News:Centurion to Sell Surplus Medical Equipment in Online and On-site Auction 2
... in Stopping their Periods, But Unsure,About Medical Implications, ... in a national survey say that they are interested ... sure if it,s safe. Yet when,physicians are polled, 97 ... is, in fact, medically safe and,acceptable. The survey results ...
... AIRES, Argentina, October 3, 2007 The first reported ... more than two-thirds of patients with moderate to severe ... achieved at least a 75 percent reduction in psoriasis ... as measured by the Psoriasis Area and Severity Index ...
... has received a five-year, $8.4 million grant from the ... survey the genetic, physical and behavioral profiles of children ... reach and ethnic diversity of the Autism Genetic Resource ... overseen by Clara Lajonchere, research assistant professor at the ...
... The Stop & Shop Supermarket,Company, Giant Food and General ... for the Cure with the Pink for the Cure Program. ... Shop/Giant,Consumer Advisor Andrea Astrachan, "and by purchasing ,Pink for the ... the fight against,breast cancer and help us donate to this ...
... Genaera,s Strategic Focus on Core Programs in Obesity ... Genaera,Corporation (Nasdaq: GENR ) today announced ... the July 2007 option to acquire from,Genaera the ... as a,drug. Pexiganan is a novel, small peptide ...
... California Nurses,Association/National Nurses Organizing Committee today condemned President,Bush,s veto ... Insurance,Program. "Listening to the overheated rhetoric coming out ... be gone but his legacy lives on," said Zenei,Cortez, ... chastised,Bush for his recent claims that legislators who passed ...
Cached Medicine News:Health News:Safe to Stop the Flow?: Differing Attitudes Found Between Women and Doctors Concerning Menstrual Suppression 2Health News:Safe to Stop the Flow?: Differing Attitudes Found Between Women and Doctors Concerning Menstrual Suppression 3Health News:Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis 2Health News:Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis 3Health News:Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis 4Health News:USC granted $8.4 million for autism research 2Health News:USC granted $8.4 million for autism research 3Health News:Stop & Shop and Giant Food Join General Mills in Pink for the Cure 2Health News:Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation 2Health News:Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation 3Health News:Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation 4Health News:California Nurses Association Blasts Bush for Veto on Children's Health 2
(Date:5/29/2015)...  The annual customer satisfaction survey of over 5,700 ... #1 across all specialties. Every year, Florida ... poll of EHR users and publishes an internationally recognized ... Praxis EMR topped 348 other systems, with the ... used by Black Book. In addition to earning the ...
(Date:5/29/2015)... BOSTON , May 29, 2015 ... automation, and contract manufacturing, and Vaxxas , a ... delivery technology, have been named winners of the 2015 ... Jet Coating Instrument , an advanced technology platform to ... The award was announced last evening at the Good ...
(Date:5/29/2015)... , May 29, 2015  Haemonetics Corporation (NYSE: ... , Chief Operating Officer, will present at the JMP ... on June 23 rd , 2015 at ... access Mr. Davies, presentation live via webcast at: ... (NYSE: HAE ) is a global healthcare company ...
Breaking Medicine Technology:Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 3
... superDimension, Ltd. ® , a privately-owned company that develops ... received FDA 510(k) clearance for the superDimension marker delivery ... Company,s Electromagnetic Navigational Bronchoscopy (ENB) system, which has treated ... David S. Wilson, MD, Columbus Regional Hospital, ...
... 2011 Medstreaming, a leading provider of medical ... fully integrated Cardiovascular PACS and certified EMR with ... components to its Cardiovascular Information System (CVIS) platform, ... offer a FDA-cleared PACS and EMR certified for ...
Cached Medicine Technology:superDimension Receives FDA 510(k) Clearance for Marker Delivery Kit 2superDimension Receives FDA 510(k) Clearance for Marker Delivery Kit 3superDimension Receives FDA 510(k) Clearance for Marker Delivery Kit 4Medstreaming Launches Fully Integrated Cardiovascular PACS and Certified EMR With Electronic Whiteboard at ACC 2Medstreaming Launches Fully Integrated Cardiovascular PACS and Certified EMR With Electronic Whiteboard at ACC 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: